Iovance Biotherapeutics, Inc. (IOVA) ownership: Top institutional holder: BlackRock, Inc. ($109.09M). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 31080505.00 | $109.09M | 2026-03-31 |
| MHR FUND MANAGEMENT LLC | 28967103.00 | $101.67M | 2026-03-31 |
| VANGUARD GROUP INC | 27207079.00 | $74.28M | 2025-12-31 |
| STATE STREET CORP | 17448108.00 | $61.24M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 16617737.00 | $58.33M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 13687433.00 | $48.04M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11700844.00 | $41.07M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 9414292.00 | $33.04M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 |
Back to IOVA overview · IOVA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.